QA: Korro Bio Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001703647_2023_Korro_Bio_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001703647, Korro Bio Inc.

  xvar xval
0 AssetsCurrent 87,493,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,739,000
3 remainder_Assets 31,006,000
4 LiabilitiesCurrent 21,026,000
5 LiabilitiesNoncurrent 26,850,000
6 remainder_Liabilities 4,167,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 33,584,000
9 ResearchAndDevelopmentExpense 49,418,000
10 remainder_Expenses 959,000
11 remainder_Revenues 0
12 remainder_NetIncome 2,381,000
13 remainder_ComprehensiveNetIncome -136,000
  yvar yval
0 Assets 121,238,000
1 Liabilities 52,043,000
2 Expenses 83,961,000
3 Revenues 0
4 StockholdersEquity 69,195,000
5 NetIncome -81,580,000
6 ComprehensiveNetIncome -81,648,000
7 BaseVar 129,879,500
8 EconomicCapitalRatio 0.431

Edgar->Model Mapping

Feature Distribution

Change over Time